P-139Chemotherapy rechallenge or reintroduction, regorafenib, and TAS-102 for metastatic pretreated colorectal cancer patients: a propensity score analysis of treatment beyond the second line (PROSERpINA Study). (2nd July 2019) - Calegari, M; Zurlo, I; Basso, M; Orlandi, A; Bensi, M; Camarda, F; Stefano, B Di; Vivolo, R; Pozzo, C; Sperduti, I; Bria, E; Salvatore, L; et al.